The National Pharmaceutical Pricing Authority (NPPA) has directed hospitals, medical institutions and pharmaceutical sellers to prominently display updated price lists of 137 non-scheduled anti-cancer drugs following the implementation of Trade Margin Rationalisation (TMR).
The revised prices, notified through a Gazette Order dated October 17, 2026, came into effect on November 9, 2026. The latest price lists, incorporating submissions received from pharmaceutical companies up to November 11, are available on the NPPA website and the Pharma Sahi Daam app and portal.
The directive applies to manufacturers, retailers, dealers, stockists, hospitals and medical institutions, which must ensure compliance with the revised maximum retail prices (MRPs) and display the updated lists prominently at their premises and on their websites.
The NPPA has also instructed State Drug Controllers to monitor implementation and ensure that the benefits of revised prices are passed on to patients. Violations, including overcharging, may invite proceedings under the Drugs (Prices Control) Order (DPCO), 2013.
Patients and consumers can report complaints related to overcharging, medicine shortages or non-availability through the Pharma Sahi Daam app or portal, the NPPA helpline at 1800-111-255, or email at monitoring-nppa@gov.in.
State Drug Controllers have been asked to submit their Action Taken Reports to the NPPA by November 16, 2026.




